— Know what they know.
Not Investment Advice

HKPD NASDAQ

Cellyan Biotechnology Co., Ltd
1W: -2.1% 1M: -28.0% 3M: -76.4% YTD: -86.4% 1Y: -92.4%
$0.11
-0.00 (-2.06%)
 
Weekly Expected Move ±10.6%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Distribution · Tech Score Sell · Power 29 · $1.2M mcap · 3M float · 87.40% daily turnover · Short 31% of daily vol

📊 Key Metrics

TTM
$23M
Revenue
+0.0% YoY
$-2M
Net Income
+0.0% YoY
$-1M
Free Cash Flow
+0.0% YoY
7.2%
Gross Margin
-19.5%
Op. Margin
-20.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-20.8%
ROA-15.5%
ROIC-14.1%

Valuation

P/E-5.0
P/B0.4
EV/EBITDA-12.6

Leverage

Debt/Equity0.13
Current Ratio3.86
Interest Cov.-10.2x

Quality Scores

Piotroski F2/9
Altman Z5.95
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms